Stock Analysis on Net

AbbVie Inc. (NYSE:ABBV)

Enterprise Value (EV) 

Microsoft Excel

Current Enterprise Value (EV)

AbbVie Inc., current enterprise value calculation

Microsoft Excel
Current share price (P) $207.55
No. shares of common stock outstanding 1,766,558,253
US$ in millions
Common equity (market value)1 366,649
Add: Noncontrolling interest (per books) 39
Total equity 366,688
Add: Short-term borrowings (per books)
Add: Current portion of long-term debt and finance lease obligations (per books) 6,804
Add: Long-term debt and finance lease obligations, excluding current portion (per books) 60,340
Total equity and debt 433,832
Less: Cash and equivalents 5,524
Less: Short-term investments 31
Enterprise value (EV) 428,277

Based on: 10-K (reporting date: 2024-12-31).

1 Common equity (market value) = Share price × No. shares of common stock outstanding
= 207.55 × 1,766,558,253


Historical Enterprise Value (EV)

AbbVie Inc., EV calculation

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Share price1, 2 $192.87 $175.75 $151.31 $144.03 $105.01
No. shares of common stock outstanding1 1,765,354,859 1,766,473,359 1,769,399,971 1,768,753,829 1,765,881,690
US$ in millions
Common equity (market value)3 340,484 310,458 267,728 254,754 185,435
Add: Noncontrolling interest (book value) 39 37 33 28 21
Total equity 340,523 310,495 267,761 254,782 185,456
Add: Short-term borrowings (book value) 1 14 34
Add: Current portion of long-term debt and finance lease obligations (book value) 6,804 7,191 4,135 12,481 8,468
Add: Long-term debt and finance lease obligations, excluding current portion (book value) 60,340 52,194 59,135 64,189 77,554
Total equity and debt 407,667 369,880 331,032 331,466 271,512
Less: Cash and equivalents 5,524 12,814 9,201 9,746 8,449
Less: Short-term investments 31 2 28 84 30
Enterprise value (EV) 402,112 357,064 321,803 321,636 263,033

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 Data adjusted for splits and stock dividends.

2 Closing price as at the filing date of AbbVie Inc. Annual Report.

3 2024 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 192.87 × 1,765,354,859


The financial data reveals a consistent upward trend across the key capital structure metrics over the five-year period under review.

Common Equity (Market Value)
This metric shows a steady increase each year, rising from $185,435 million in 2020 to $340,484 million in 2024. This growth indicates a significant appreciation in market valuation of the company's equity, reflecting positive market sentiment or operational performance enhancements.
Total Equity
Total equity closely follows the same upward trajectory as common equity, starting at $185,456 million in 2020 and reaching $340,523 million by 2024. The parallel movement between common equity and total equity suggests limited influence from other equity components such as preferred stock, indicating the majority of equity is common stock.
Total Equity and Debt
The combined metric of equity and debt demonstrates moderate growth, increasing from $271,512 million in 2020 to $407,667 million in 2024. While the absolute increase is notable, the growth pace is somewhat slower relative to the increase in common equity alone, suggesting a relatively stable or controlled use of debt financing.
Enterprise Value (EV)
Enterprise value reflects the overall valuation of the company by the market, incorporating equity and debt minus cash and equivalents. EV has increased from $263,033 million in 2020 to $402,112 million in 2024, showing a consistent rise parallel to both equity and total capital employed metrics. This trend indicates improving market perception and possibly capitalization on growth opportunities.

Overall, the data shows strengthening financial position with increasing market valuation and equity base supported by stable debt levels. The consistent increase in enterprise value aligns with the expanding capital base, suggesting positive investor confidence and value creation over the period assessed.